![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 49, 46031-46038, December 7, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B Ligand*
**,
**,
,
From the Glycosphingolipids and their
metabolites play important roles in a variety of biological processes.
Several signal molecules are localized in a glycolipid-enriched
microdomain on the cell surface, and their signals are regulated by the
glycolipid composition. However, the function of glycolipids in
osteoclastogenesis has not been clearly understood. We found that
D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP), a glucosylceramide synthase inhibitor, completely
inhibits the osteoclast formation induced by
macrophage-colony-stimulating factor and receptor activator of nuclear
factor-
First Department of Oral and Maxillofacial
Surgery and the Departments of § Pediatric Dentistry,
Preventive Dentistry, and ** Pharmacology, Nagasaki
University School of Dentistry, Nagasaki 852-8588, the

Department of Biomembrane and Biofunctional
Chemistry, Graduate School of Pharmaceutical Sciences, Hokkaido
University, Sapporo 060-0812, and the
§§ Department of Biochemistry II, Nagoya
University School of Medicine, Nagoya 466-0065, Japan
B ligand (RANKL) in a dose-dependent manner.
Expression of RANK, the receptor of RANKL, induced by macrophage
colony-stimulating factor, was reduced markedly in
D-PDMP-treated cells. D-PDMP also inhibited the
phosphorylation of the inhibitor of nuclear factor-
B and
extracellular signal-regulated kinase 1/2 induced by RANKL. In several
experiments with the addition of glycolipids to
D-PDMP-treated purified bone marrow cells, lactosylceramide (LacCer) strongly affected the differentiation into tartrate-resistant acid phosphatase mononucleated cells, but not positive multinucleated cells. GM3 and GM1 also recovered, but less effectively compared with LacCer. Moreover, exogenous LacCer recovered the reduced expression of RANK and the phosphorylation of inhibitor of NF-
B and
extracellular signal-regulated kinase 1/2 after stimulation by RANKL at
the same level of cells without D-PDMP treatment. Our data
suggest that glycosphingolipids, especially LacCer, are necessary for
the initiation step of RANKL-induced osteoclastogenesis.
This article has been cited by other articles:
![]() |
H. Yoshida, K. Okamoto, T. Iwamoto, E. Sakai, K. Kanaoka, J.-P. Hu, M. Shibata, H. Hotokezaka, K. Nishishita, A. Mizuno, et al. Pepstatin A, an Aspartic Proteinase Inhibitor, Suppresses RANKL-Induced Osteoclast Differentiation. J. Biochem., March 1, 2006; 139(3): 583 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rajesh, A. Kolmakova, and S. Chatterjee Novel Role of Lactosylceramide in Vascular Endothelial Growth Factor-Mediated Angiogenesis in Human Endothelial Cells Circ. Res., October 14, 2005; 97(8): 796 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saito, N. Ohara, H. Hotokezaka, S. Fukumoto, K. Yuasa, M. Naito, T. Fujiwara, and K. Nakayama Infection-induced Up-regulation of the Costimulatory Molecule 4-1BB in Osteoblastic Cells and Its Inhibitory Effect on M-CSF/RANKL-induced in Vitro Osteoclastogenesis J. Biol. Chem., April 2, 2004; 279(14): 13555 - 13563. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ha, H. B. Kwak, S. K. Lee, D. S. Na, C. E. Rudd, Z. H. Lee, and H.-H. Kim Membrane Rafts Play a Crucial Role in Receptor Activator of Nuclear Factor kappa B Signaling and Osteoclast Function J. Biol. Chem., May 9, 2003; 278(20): 18573 - 18580. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Demer Adipose Rex: Fat and Fats That Rule Differentiation Circ. Res., February 22, 2002; 90(3): 241 - 243. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |